Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Am J Gastroenterol. 2022 Aug 12;117(11):1764–1771. doi: 10.14309/ajg.0000000000001935

Table 3:

Comparison of clinical characteristics of patients with and without an EGD

No EGD (n=694) EGD (n=433) p value

Age, mean ± SD 65.5 ± 8.5 64.7 ± 8.7 0.13
 51–59 201 (29.0) 134 (31) 0.71
 60–69 234 (33.7) 149 (34.4)
 70–79 246 (35.4) 140 (32.3)
 80+ 13 (1.9) 10 (2.3)

Hispanic or Latino, n (%) 5 (0.7) 8 (1.9) 0.09

BMI, mean ± SD 30.4 ± 5.9 29.6 ± 5.8 0.04
 <24.9 112 (16.1) 80 (18.5)
 25.0–29.9 259 (37.3) 172 (39.7)
 >30 323 (46.6) 181 (41.8)

Smoking Status, n (%) 0.48
 Current 109 (15.7) 72 (16.6)
 Former 322 (46.4) 185 (42.7)
 Never 263 (37.9) 176 (40.7)

Employment status, n (%) 0.59
 Employed 259 (43.5) 156 (41.7)
 Unemployed 337 (56.5) 218 (58.3)

Marital status, n (%) 0.02
 Married 488 (74.4) 283 (68.0)
 Not married 168 (25.6) 133 (33.0)

Insurance Status, n (%) 0.58
 No insurance 34 (4.9) 19 (4.4)
 Private 274 (39.5) 169 (39.0)
 Medicare 370 (53.3) 229 (52.9)
 Medicaid 16 (2.3) 16 (3.7)

Primary Care Specialty, n (%) <0.01
 Internal Medicine 157 (22.6) 145 (33.5)
 Family Medicine 537 (77.4) 288 (66.5)

GERD medications, n (%)
 PPI 640 (92.2) 416 (96.1) 0.01
 H2-blockers 219 (31.6) 189 (43.6) <0.01
 Baclofen 16 (2.3) 10 (2.3) 0.99
 Carafate 40 (4.8) 88 (20.3) <0.01
 Over-the-counter agents 157 (22.6) 136 (31.4) <0.01
 Use of >1 medications 268 (38.6) 227 (52.4) <0.01

GERD Symptoms on Treatment, n (%) 151 (21.8) 337 (78) <0.01